Clinical trial No longer in our active list Observational

Using Optical Genome Mapping to Identify Genetic Variants in Patients

Official title: Validation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal Cohort

Run by Bionano Genomics · NCT05295277 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing a new method called Optical Genome Mapping to see if it can find genetic changes in patients with developmental and intellectual disabilities better and faster than current genetic tests.

Quick facts

Study typeObservational
SexAll
Enrollment1000 (estimated)
SponsorBionano Genomics
Industry-sponsored
Locations8 sites (Atlanta, Georgia and 7 other locations)
Trial IDNCT05295277 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with previously identified genomic aberrations from standard genetic tests or those with negative results but still suspected of having genetic conditions.

Probably not a fit

Patients with specific genetic variants or those who opted out of research at the testing laboratory may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to validate Optical Genome Mapping (OGM) as a method for detecting genomic structural variants in patients with various developmental and intellectual disabilities. The study will compare the results of OGM with those obtained from standard genetic testing methods, such as chromosomal microarray analysis and next-generation sequencing. By analyzing ultra-long DNA molecules, OGM can identify a wide range of genetic alterations, including deletions and duplications, and provide results within a few days. The study involves a multi-site approach, gathering data from several institutions to assess the effectiveness of this new technology.

Why it matters

Potential benefit: If successful, this study could provide a faster and more comprehensive method for identifying genetic variants that contribute to developmental and intellectual disabilities.

How similar studies have gone: Other studies have shown promising results for Optical Genome Mapping, indicating its potential effectiveness compared to standard testing methods.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Individual with a genomic aberration identified by CMA, karyotyping, Southern blot analysis, PCR, FISH, and/or NGS or other standard of care (SOC) genetic testing technology whose clinical test results are available to compare with results from OGM.
2. Patients with prior negative SOC genetic testing results whose results are available to compare with results from OGM.

Exclusion Criteria:

1. Any individual who opted-out of research at the testing laboratory.
2. An individual whose genetic test contains the following variants: pathogenic sequence variants, abnormalities involving acrocentric p-arms and centromeres, below 20% for mosaicism, and tetraploidy.

Where it's running

  • Greenwood Genetic Center
    Greenwood, South Carolina, United States
    Recruiting
  • Lineagen (A Bionano Genomics Company)
    Salt Lake City, Utah, United States
    Recruiting
  • Praxis Genomics
    Atlanta, Georgia, United States
    Active not recruiting
  • Augusta University Research Institute
    Augusta, Georgia, United States
    Active not recruiting
  • University of Iowa Hospitals & Clinics, Molecular Pathology
    Iowa City, Iowa, United States
    Active not recruiting
  • Columbia University Irving Medical Center
    New York, New York, United States
    Active not recruiting
Show 2 more locations
  • DNA Microarray CGH Laboratory, Department of Pathology, University of Rochester Medical Center
    W. Henrietta, New York, United States
    Active not recruiting
  • Medical College of Wisconsin
    Milwaukee, Wisconsin, United States
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.